Workflow
1 Energy Stock With a Dividend Yield Over 7% Right Now
The Motley Fool· 2025-06-15 00:33
The energy sector can be a great place for income investors to find higher-yielding options. The average energy stock in the S&P 500 has a yield of around 3% at its current share price, which is more than double the 1.3% yield of the broad market index. Many energy stocks have even higher yields. One of them is MPLX (MPLX -0.08%). The midstream energy company yields more than 7% right now. Here's why income investors will want to take a closer look at MPLX. A high-quality, high-yielding payoutA yield above ...
Scott+Scott Attorneys at Law LLP Reminds Investors of Its Current Investigation Into Compass Diversified Holdings (NYSE: CODI)
GlobeNewswire News Room· 2025-06-14 23:56
NEW YORK, June 14, 2025 (GLOBE NEWSWIRE) -- Scott+Scott Attorneys at Law LLP (“Scott+Scott”), a shareholder and consumer rights litigation firm, is investigating whether Compass Diversified Holdings (“Compass” or the “Company”) (NYSE: CODI) or certain of its officers and directors issued misleading and false statements and/or failed to disclose information material to investors in violation of federal securities laws. CLICK HERE TO RECEIVE ADDITIONAL INFORMATION ABOUT THIS POTENTIAL CLASS ACTION Compass own ...
Wells Fargo: Higher Interest Rates Create Fixed Income Opportunities
Seeking Alpha· 2025-06-14 23:40
Wells Fargo (NYSE: WFC ) doesn’t need a long introduction, as this US-based financial institution enjoys a worldwide name and brand recognition. In my previous articles I focused on some of the bank’s preferred shares as I liked the risk/reward ratio ofHe is the leader of the investment group European Small Cap Ideas which offers exclusive access to actionable research on appealing Europe-focused investment opportunities not found elsewhere. The a focus is on high-quality ideas in the small-cap space, with ...
HostColor Expands Its AMD Dedicated Server Offerings in LA and New York
GlobeNewswire News Room· 2025-06-14 23:28
New York, New York, June 14, 2025 (GLOBE NEWSWIRE) -- HostColor.com (HC) has announced the immediate availability of bare metal servers powered by AMD Ryzen and AMD EPYC processors in several new data center locations.  HostColor.com (HC), a globally recognized provider of cloud infrastructure and managed services, has announced the availability of custom-built, high-bandwidth, high-performance AMD dedicated server platforms in several new data center locations. HostColor's new primary New York City service ...
Ram Brand Launches 'Never Stop Being American' Marketing Campaign, New Brand Ethos 'Nothing Stops Ram'
Prnewswire· 2025-06-14 23:09
"Never Stop Being American" marketing campaign takes off across broadcast and Ram brand's social media channels Campaign celebrates America, its people, pastimes and traditions, formally introduces the Ram brand's new tagline, "Nothing Stops Ram" Set to a custom version of "The Star-Spangled Banner" by Kenny Wayne Shepherd, the spot launches on Flag Day UFC's Dana White narrates the Ram brand anthem Launch follows on the heels of brand's recent announcements that the HEMI® V-8 has returned to Ram and Ram b ...
Celldex Presents Data Demonstrating Profound Long Term Improvement in Angioedema in Barzolvolimab Phase 2 Study in Chronic Spontaneous Urticaria at EAACI 2025
Globenewswire· 2025-06-14 22:48
文章核心观点 公司宣布在慢性自发性荨麻疹(CSU)的2期临床试验中,barzolvolimab在52周时显著改善血管性水肿,数据进一步支持其临床益处,公司正进行全球3期项目 [1][2][8] 分组1:Barzolvolimab介绍 - Barzolvolimab是一种人源化单克隆抗体,能高特异性结合受体酪氨酸激酶KIT并抑制其活性,目前正研究用于多种疾病,未来还有更多适应症计划 [4] 分组2:2期CSU研究情况 - 研究为随机、双盲、安慰剂对照、平行组2期研究,评估barzolvolimab多剂量方案在有症状CSU患者中的疗效和安全性,确定最佳给药策略 [5][7] - 208名患者按1:1:1:1比例随机分配接受不同剂量barzolvolimab或安慰剂皮下注射,16周安慰剂对照治疗期后进入36周活性治疗期,52周后进入24周随访期 [7] - barzolvolimab达到研究主要疗效终点,与安慰剂相比,所有剂量水平在第12周UAS7较基线有统计学显著变化 [7] 分组3:2期CSU研究关键发现 - 77%基线时有血管性水肿的150 mg Q4W治疗患者在第52周无血管性水肿 [5][6] - 第52周,150 mg Q4W组血管性水肿症状较基线平均降低86%,300 mg Q8W组降低82% [6] - 接受barzolvolimab治疗的患者在52周治疗期间高达72%的时间无血管性水肿 [6] - 第52周,高达87%的患者报告AAS7有临床意义的改善(>8分) [6] 分组4:3期项目情况 - 公司目前正为barzolvolimab在CSU开展全球3期项目,由两项3期试验组成,旨在确定其在经H1抗组胺治疗仍有症状的成年CSU患者中的疗效和安全性,研究也包括经生物制剂治疗仍有症状的患者,目前正在招募患者 [8] 分组5:慢性自发性荨麻疹(CSU)介绍 - CSU特征为出现荨麻疹或风疹6周或更长时间且无明确特定触发因素或原因,皮肤肥大细胞激活导致皮肤瘙痒、肿胀和炎症发作,可能持续数年甚至数十年,目前疗法仅对部分患者有症状缓解作用 [9] 分组6:公司介绍 - 公司致力于免疫学新领域,追求基于抗体的新型治疗方法,改善过敏、炎症和自身免疫性疾病患者生活 [10]
Collect Double-Digit Yields From Niche Fixed-Income
Seeking Alpha· 2025-06-14 22:30
高收益投资机会 - 公司提供高股息投资组合服务 目标收益率为9-10% [4] - 公司推广"收入方法"投资策略 旨在简化退休投资流程 [4] - 公司会员服务即将涨价 当前价格为599美元 [4] 客户行为观察 - 金融机构观察到有老年客户每月定期查看最新存贷款利率 [1]
Amgen: Imdelltra Data And Q1 Results Impress
Seeking Alpha· 2025-06-14 22:30
公司表现 - Amgen(AMGN)股价在以色列和伊朗战争爆发后仍保持在成交量加权平均价格(VWAP)之上,且过去一个月上涨约15% [1] 研究机构 - Allka Research拥有20多年投资经验,专注于为个人投资者发掘ETF、大宗商品、科技和制药领域的低估资产 [2] - 该机构以保守投资策略著称,致力于简化投资策略,使经验丰富的投资者和新手都能参与 [2] - Allka Research通过Seeking Alpha平台分享投资分析,旨在建立知情投资者社区 [2] 分析师持仓 - 分析师持有辉瑞(PFE)的多头头寸,包括股票、期权或其他衍生品 [3]
Generational Buying Opportunity: Dividend Growth Machines For The AI Boom
Seeking Alpha· 2025-06-14 22:29
个人背景 - Samuel Smith曾担任多家知名股息股票研究公司的首席分析师和副总裁[1] - 拥有土木工程与数学学士学位(美国西点军校)及工程学硕士学位(德州农工大学,主攻应用数学与机器学习)[1] - 具备专业工程师和项目管理专业人士资质[1] 投资团队与服务 - 领导High Yield Investor投资团队,与Jussi Askola和Paul R Drake合作[2] - 投资策略注重安全性、增长性、收益率与价值的平衡[2] - 提供实盘核心组合、退休组合和国际组合服务[2] - 包含定期交易提醒、教育内容和投资者互动聊天室[2]
Jasper Therapeutics Reports Positive Data from 180mg Cohort in SPOTLIGHT Study of Briquilimab in Chronic Inducible Urticaria
Globenewswire· 2025-06-14 22:00
11 of 12 participants (92%) enrolled in the 180mg cohort achieved a complete response 12 of 12 participants (100%) in the 180mg cohort achieved a clinical response Tryptase levels below the lower limit of quantification observed in 10 of 12 participants (83%) No serious adverse events and no grade 3 or higher adverse events reported in the 180mg cohort Company to host conference call and webinar on Monday, June 16, at 8:00 a.m. EDT REDWOOD CITY, Calif., June 14, 2025 (GLOBE NEWSWIRE) -- Jasper Therapeutics, ...